ACCC wrote a letter to Senate Finance Committee Chairman Ron Wyden and Ranking Member Mike Crapo regarding drug pricing legislation being worked on by members of Congress. The letter asks that Congress remove providers from the middle of proposed drug pricing negotiations between the federal government and drug manufactures, siting the potential for negative repercussions on cancer care providers and their patients.
